Qube Research & Technologies (QRT)
DFTX

Qube Research & Technologies (QRT)’s Definium Therapeutics DFTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.05M Buy
+426,055
New +$7.23M 0.01% 1406
2024
Q2 		– Sell
-116,327
Closed -$1.09M – 4402
2024
Q1 		$1.09M Buy
116,327
+22,678
+24% +$129K ﹤0.01% 2094
2023
Q4 		$343K Buy
93,649
+84,644
+940% +$255K ﹤0.01% 2510
2023
Q3 		$28.2K Buy
+9,005
New +$37K ﹤0.01% 3040

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DFTX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 426,055 shares worth $8.05M. The stake represents 0.01% of the portfolio and ranks #1406 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in DFTX as recently as Q1 2024.

Qube Research & Technologies (QRT) first reported a position in DFTX in Q3 2023 and has held it in 4 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 426,055 shares of Definium Therapeutics worth $8.05M as of Q1 2026.
  • Definium Therapeutics was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Definium Therapeutics made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1406 holding.
  • Qube Research & Technologies (QRT) first reported a position in Definium Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.